---
layout: full_article
title: "DETECTION METALLO-BETA-LACTAMASE GENE IMP-1 AND IMP-2 OF Pseudomonas aeruginosa CLINICAL ISOLATES IN SANGLAH HOSPITAL BALI"
author: "Ni Made Adi Tarini, Ni Nengah Dwi Fatmawati, I Putu Bayu Mayura"
categories: jbb
canonical_url: https://jurnal.harianregional.com/jbb/full-18675 
citation_abstract_html_url: "https://jurnal.harianregional.com/jbb/id-18675"
citation_pdf_url: "https://jurnal.harianregional.com/jbb/full-18675"  
comments: true
---

<a name="caption1"></a>
<h1><a name="bookmark0"></a><span class="font8" style="font-weight:bold;"><a name="bookmark1"></a>DETECTION METALLO-BETA-LACTAMASE GENE IMP-1 AND IMP-2 OF </span><span class="font8" style="font-weight:bold;font-style:italic;">Pseudomonas aeruginosa</span><span class="font8" style="font-weight:bold;"> CLINICAL ISOLATES IN SANGLAH HOSPITAL BALI</span></h1>
<p><span class="font7" style="font-weight:bold;">Ni Made Adi Tarini<sup>1,2*</sup>, Ni Nengah Dwi Fatmawati<sup>1,2,3</sup>, and I Putu Bayu Mayura<sup>1 </sup></span><span class="font7"><sup>1</sup>Department of Clinical Microbiology, Medical School, Faculty of Medicine, Udayana University <sup>2</sup>Clinical Microbiology Laboratory, Sanglah General Hospital <sup>3</sup>Molecular Biology Laboratory, Faculty of Medicine, Udayana University *Corresponding author : </span><a href="mailto:nmatarini@unud.ac.id"><span class="font7">nmatarini@unud.ac.id</span></a></p>
<p><span class="font7" style="font-weight:bold;">ABSTRACT</span></p>
<p><span class="font7" style="font-style:italic;">Pseudomonas aeruginosa</span><span class="font7"> is a pathogen frequently found as an agent of Hospital Acquired infections. This bacterium is very easy to be resistant to several types of antibiotics through various mechanisms. Carbapenem such as Imipenem and Meropenem is a potential option for the therapy of this bacterium, but unfortunately </span><span class="font7" style="font-style:italic;">P. aeruginosa</span><span class="font7"> has ability in hydrolyzing these antibiotics through enzyme metallo-β-lactamases (MBLs). Recently, IMP and VIM, MBLs enzyme group are reported common from various countries, but no data is reported for these enzymes in Indonesia especially in Bali. In fact, the resistant data of </span><span class="font7" style="font-style:italic;">P. aeruginosa</span><span class="font7"> against carbapenem group antibiotics such as meropenem and imipenem is quite high in Sanglah General Hospital in 2014 was 35% and 45% respectively. Therefore, the aim of this study was to detect IMP-1 and IMP-2 genes of MDR </span><span class="font7" style="font-style:italic;">P. aeruginosa,</span><span class="font7"> which are phenotypically resistant to the antibiotic Imipenem and Meropenem disks based on CLSI standards in Clinical Microbiology Laboratory, Sanglah General Hospital, Denpasar, Bali. Eighty-six isolates were isolated from sputum (25 / 29.1%), wound (25 / 29.1%), urine (15 / 17.4%), endotracheal Tube (11 / 12.8), pus (6/7% ), blood (3 / 3.5%) and tissue (1 / 1.1%). In this study, all isolates were subjected to PCR for detection of IMP-1 and IMP-2. The result showed that 9 isolates were positive IMP-1 gene (10.5%), but there was no isolate positive for IMP-2 gene. The result was similar with that of the other countries, especially for the gene IMP-1. Detection and molecular characterization of MBL-producing </span><span class="font7" style="font-style:italic;">P. aeruginosa</span><span class="font7"> strains are very important for infection control purposes. Currently, this study is still continued for detection of another MBL genes.</span></p>
<p><span class="font7">Keyword : </span><span class="font7" style="font-style:italic;">Pseudomonas aeruginosa,</span><span class="font7"> MBLs gene, PCR, Positive Control</span></p>
<h1><a name="bookmark2"></a><span class="font8" style="font-weight:bold;"><a name="bookmark3"></a>INTRODUCTION</span></h1>
<p><span class="font8">Bacterial Multidrug Resistance (MDR) is an indicator of the changes in the strains of bacteria that are often associated with the administration of antibiotic unwisely, such as unnecessary empirical therapy, the selection of antibiotic regimens improperly, and prolonged use of antibiotics. One of bacteria found in hospital setting that easy to become an MDR bacteria is </span><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa</span><span class="font8">. It is a pathogen frequently found as an agent of Hospital Acquired infections. This bacterium is very easy to be resistant to several types of antibiotics through various mechanisms. Prolonged use of antibiotics causing this bacteria to become resistant immediately</span></p>
<p><span class="font8">against several groups of antibiotics such as Beta-lactam, Aminoglycosides, Chloramphenicol, Quinolone, Tetracycline and Sulphonamides. Thereby making the infections caused by these bacteria very difficult to treat ( Arunagiri K </span><span class="font8" style="font-style:italic;">et al.,</span><span class="font8">2012). Carbapenem, such as Imipenem and Meropenem, is a potential option for the therapy of this bacterium, but unfortunately </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> has an ability in hydrolyzing these antibiotics through enzyme metallo-β-lactamases (MBLs). (Zhao WH </span><span class="font8" style="font-style:italic;">et al.,</span><span class="font8"> 2009). Prevalence rates of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> produce MBLs vary widely. Study in India in 2012 reported MDR </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> isolate produced MBLs in 70.1% of isolates, which was higher than that in 2002 that is only</span></p>
<p><span class="font8">12% (Arunagiri K </span><span class="font8" style="font-style:italic;">et al.,</span><span class="font8"> 2012). Several types of MBLs reported from </span><span class="font8" style="font-style:italic;">Enterobacteriaceae</span><span class="font8"> and Gram-negative nonfermenter group bacteria such as IMP, VIM, SPM, SIM and GIM isolated from clinical specimens. Enzymes such as IMP and VIM are two groups of enzymes were predominantly found in the previous studies (Giske CG </span><span class="font8" style="font-style:italic;">et al.,</span><span class="font8"> 2006). Moreover, both of enzymes are also found predominantly in Asia. Recently, IMP and VIM, MBLs enzyme group are reported commonly found from various countries. Study in India, 2012, the MDR </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> isolates showed that both of MBLs gene such as </span><span class="font8" style="font-style:italic;">bla</span><span class="font8">VIM genes and </span><span class="font8" style="font-style:italic;">bla</span><span class="font8">IMP gene were 87.2% and 4.3%, respectively. However, it has been different with study conducted in Iran in the same year, which reported </span><span class="font8" style="font-style:italic;">bla</span><span class="font8">VIM gene and </span><span class="font8" style="font-style:italic;">bla</span><span class="font8">IPM gene were18.2% and 9,6%, respectively. (Sepehriseresht S </span><span class="font8" style="font-style:italic;">et al.,</span><span class="font8"> 2012). No data is reported for MBLs enzymes in Indonesia especially in Bali. In fact, the resistant data of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> against Carbapenem group antibiotics such as Meropenem and Imipenem is quite high in Sanglah General Hospital in 2014 was 35% and 45% respectively. Based on this condition, therefore, the aim of this study was to detect IMP-1 and IMP-2 genes of MDR </span><span class="font8" style="font-style:italic;">P. aeruginosa,</span><span class="font8"> which &nbsp;&nbsp;are</span></p>
<p><span class="font8">phenotypically resistant to the antibiotic Imipenem and Meropenem disks based on CLSI standards in Clinical Microbiology Laboratory, Sanglah General Hospital, Denpasar, Bali using PCR.</span></p>
<p><span class="font8" style="font-weight:bold;">MATERIALS AND METHODS</span></p>
<h1><a name="bookmark4"></a><span class="font8" style="font-weight:bold;"><a name="bookmark5"></a>Bacterial isolates and identification</span></h1>
<p><span class="font8">Eighty-six glycerol stock isolates of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> were cultured on MacConkey</span></p>
<p><span class="font8">Agar and incubated aerobically at 35±2°C, 18-24h. The isolates were isolated from sputum (25 / &nbsp;29.1%), wound (25 / 29.1%),</span></p>
<p><span class="font8">urine (15 / 17.4%), Endotracheal Tube (11 / 12.8), pus (6/7%), blood (3 / 3.5%) and tissue (1 &nbsp;/ &nbsp;1.1%) during 2013-2015.</span></p>
<p><span class="font8">Identification of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and</span></p>
<p><span class="font8">drug susceptibility test by VITEK-2 based on CLSI Standard.</span></p>
<h1><a name="bookmark6"></a><span class="font8" style="font-weight:bold;"><a name="bookmark7"></a>Bacterial Genomic DNA Isolation</span></h1>
<p><span class="font8">Isolates of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> that have grown on MacConkey agar plates were harvested around 5-10 colonies and suspended in 200 μl PBS (Phosphate Buffered Saline) pH 7.3. Bacterial genomic DNA was isolated by using Roche High Pure PCR Template Isolation Kit (Roche Life Science, Indianapolis, USA) based on manufacturer’s instruction from bacterial suspension. DNA was eluted with 50 μl of elution buffer.</span></p>
<h1><a name="bookmark8"></a><span class="font8" style="font-weight:bold;"><a name="bookmark9"></a>PCR for &nbsp;</span><span class="font8" style="font-weight:bold;font-style:italic;">bla</span><span class="font8" style="font-weight:bold;">IMP1 and </span><span class="font8" style="font-weight:bold;font-style:italic;">bla</span><span class="font8" style="font-weight:bold;">IMP2</span><br><br><span class="font8" style="font-weight:bold;"><a name="bookmark10"></a>gene</span></h1>
<p><span class="font8">PCR was conducted using Go Taq<sup>® </sup>Green Master Mix (Promega, Madison, USA). Uniplex PCR to detect 16S rRNA gene was performed. It was followed by Uniplex PCR to detect &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IMP-1 and</span></p>
<p><span class="font8">IMP-2 gene used primer Listed in Table 1. The final concentration of primers were 0.4 μM each. Protocols of PCR were described in previous study (Sepehriseresht et al, 2012). PCR cycle was initiated with pre denaturation at 94°C for 3 min; 35 cycles of denaturation at 94°C for 1 min, annealing primer at 55°C (16sRNA and IMP-1) and 48<sup>o</sup>C (IMP-2) for 1 min and extension at 72°C for 1 min; and final extension at 72°C for 7 min (iCycler, Biorad thermal cycler).</span></p>
<p><span class="font1">ISSN ONLINE: 9 772303 337 008</span></p>
<p><span class="font8" style="font-weight:bold;">Table 1. Primer used for Gene VIM and IPM Detection (Shibata et al.,2003)</span></p>
<table border="1">
<tr><td style="vertical-align:top;">
<p><span class="font7" style="font-weight:bold;">No.</span></p></td><td style="vertical-align:top;">
<p><span class="font7" style="font-weight:bold;">Nama Primer &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sekuens Primer (5'</span><span class="font3" style="font-weight:bold;">÷ </span><span class="font7" style="font-weight:bold;">3’) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;bp</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7">1.</span></p></td><td style="vertical-align:top;">
<p><span class="font7" style="font-style:italic;">bla</span><span class="font7">IMP1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward: ACC GCA GCA GAG TCT TTG CC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;587</span></p>
<p><span class="font7">Reverse: ACA ACC AGT TTT GCC TTA CC</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font7">2.</span></p></td><td style="vertical-align:middle;">
<p><span class="font7" style="font-style:italic;">bla</span><span class="font7">IMP2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward: GTT TTA TGT GTA TGC TTC C &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;678</span></p>
<p><span class="font7">Reverse: AGC CTG TTC CCA TGT AC</span></p></td></tr>
</table>
<p><span class="font8">Amplicons were electrophoresed on 1.5% agarose gel in TBE buffer at 60 volt, and for 35 min. DNA was visualized with GelRed™ Nucleic Acid Gel Stain (Biotium, Hayward, CA 94545) and</span></p>
<h1><a name="bookmark11"></a><span class="font8" style="font-weight:bold;"><a name="bookmark12"></a>RESULTS AND DISCUSSION</span></h1>
<p><span class="font8">A total of 86 glycerol stock isolates of </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> from clinical samples, which were phenotypicall resistant to antibiotics imipenem and meropenem using VITEK-2 based on CLSI Standard, were suscessfully cultured on MacConkey agar media plates. The colonies showed pale yellow colonies. All clinical isolates were positive tested for the presence of 16sRNA</span></p>
<p><span class="font8">gene (Fig.1), confirmed that all isolates were </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8">. All isolates were subjected to PCR for detection of IMP-1 and IMP-2. The result showed that 9 (10.5%) isolates were positive IMP-1 gene (Fig.2), but none of isolate was positive for IMP-2 gene. The study to detect MBLs gene have been conducted in the other countries. Study in Iran showed that 6.6% and 3.3% of the </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> had IMP-1 and IMP-2 genes, respectively (Sepehriseresht S et al,2012). In Asian Countries and regions, two MBLs gene are commonly prevalent. Study in Japan showed IMP-1 gene was 0.5% and IMP-2 was 64.5% (Shibata et al, 2003), whereas in China reported that IMP-1 type of MBLs was 89.7% (Arunagiri K, 2012)</span></p>
<div>
<p><span class="font4">500 bp</span></p>
</div><br clear="all">
<div>
<p><span class="font4">100 bp</span></p>
</div><br clear="all">
<div>
<p><span class="font4" style="font-weight:bold;">1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 &nbsp;&nbsp;&nbsp;3 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 &nbsp;&nbsp;&nbsp;5</span></p><img src="https://jurnal.harianregional.com/media/18675-1.jpg" alt="" style="width:181pt;height:169pt;">
</div><br clear="all">
<div>
<p><span class="font4" style="font-weight:bold;">214 bp</span></p>
</div><br clear="all">
<p><span class="font8" style="font-weight:bold;">Fig. 1. PCR for 16sRNA gene detection. The expected band was 214 bp. Amplicon was electrophoresed on 1.5% agarose gel. </span><span class="font8">(M = Marker 100 bp; Lane 2 - 5 = 16sRNA positive band = 214 bp)</span></p>
<div>
<p><span class="font4">1 &nbsp;&nbsp;&nbsp;&nbsp;2 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 &nbsp;&nbsp;&nbsp;&nbsp;4 &nbsp;&nbsp;&nbsp;5 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6 &nbsp;&nbsp;&nbsp;7 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8 &nbsp;&nbsp;&nbsp;&nbsp;9 &nbsp;&nbsp;&nbsp;10</span></p>
<p><span class="font4" style="font-weight:bold;">500 bp</span></p>
<p><span class="font4" style="font-weight:bold;">100 bp</span></p><img src="https://jurnal.harianregional.com/media/18675-2.jpg" alt="" style="width:399pt;height:119pt;">
<p><span class="font4" style="font-weight:bold;">587 bp</span></p>
<p><span class="font8" style="font-weight:bold;">Fig. 2. PCR for IMP-1 gene detection. Lanes 5,6 and 9 were positif for IMP-1 gene (587 bp). Amplicon was electrophoresed on 1.5% agarose gel. </span><span class="font8">(lane 1 = marker, lane 2 = negative control )</span></p>
</div><br clear="all">
<p><span class="font8">This study showed the similar condition with the MBL gene research studies from the other countries, especially for the gene IMP-1. However, it was slightly different for IMP-2 gene. Detection and molecular characterization of MBL-producing </span><span class="font8" style="font-style:italic;">P. aeruginosa</span><span class="font8"> strains very important for infection control purposes. Currently, this study is still continued for detection of another MBL genes.</span></p>
<p><span class="font8" style="font-weight:bold;">ACKNOWLEDGMENTS</span></p>
<p><span class="font8">This work was financially supported by Hibah LITBANG Medicine Faculty Udayana University, Bali, Indonesia under Grant No. No. 2672/UN14/KU/2014 . We</span></p>
<p><span class="font8">thank Wahyu Hidayati (Molecular Biology Laboratory staff), Putu Yuliandari, M.D. (Clinical Microbiology Laboratory, Faculty of Medicine staff), and Ni Wayan Nilawati (Clinical Microbiology Laboratory Sanglah General Hospital staff) for their technical supports.</span></p>
<p><span class="font8" style="font-weight:bold;">REFERENCES</span></p>
<p><span class="font8">Arunagiri, K., Sekar, B., Sangeetha, G., John, J. (2012). Detection and Characterization of Metallo- β-Lactamases in </span><span class="font8" style="font-style:italic;">Pseudomonas</span></p>
<p><span class="font8" style="font-style:italic;">aeruginosa</span><span class="font8"> by &nbsp;phenotypic &nbsp;and</span></p>
<p><span class="font8" style="font-weight:bold;">Molecular &nbsp;&nbsp;&nbsp;Methods &nbsp;&nbsp;&nbsp;from</span></p>
<p><span class="font8" style="font-weight:bold;">Clinical &nbsp;&nbsp;&nbsp;Samples &nbsp;&nbsp;&nbsp;in</span></p>
<p><span class="font8" style="font-weight:bold;">Tertiary Care Hospital, West Indian Med J, 61(8), 778-783.</span></p>
<p><span class="font8" style="font-weight:bold;">Bush, K., Jacoby, G.,A., Medeiros, A.,A. (1995). Afunctional classification scheme for beta &nbsp;&nbsp;&nbsp;lactamases</span></p>
<p><span class="font8" style="font-weight:bold;">and its correlation with molecular structure. Antimicrob Agents Chemother., 39, 1211-1233.</span></p>
<p><span class="font8" style="font-weight:bold;">Castanheira, M., Toleman, M.,A., Jones, R.,N., Schmidt, F.,J., Walsh,T.,R. (2004). &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Molecular</span></p>
<p><span class="font8" style="font-weight:bold;">characterization of a β-lactamase gene, &nbsp;&nbsp;&nbsp;</span><span class="font8" style="font-weight:bold;font-style:italic;">bla</span><span class="font8" style="font-weight:bold;">GIM-1,</span></p>
<p><span class="font8" style="font-weight:bold;">encoding a new subclass of </span><span class="font8">metallo-β &nbsp;&nbsp;&nbsp;&nbsp;lactamase. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Antimicrob</span></p>
<p><span class="font8">Agents Chemother., 48, 4654-4661.</span></p>
<p><span class="font8">Giske, G.,C., Libisch, B., Colinon, C., Scoulica, e., et al. (2006). Establishing Clonal Relationships between VIM-1-like Metallo-β-Lactamases-Producing </span><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa</span><span class="font8"> Strain from &nbsp;&nbsp;&nbsp;Four &nbsp;&nbsp;&nbsp;European</span></p>
<p><span class="font8">Countries by Multilocus Sequence Typing, J. Clin. Microbiol, 44(12), 4309-4315.</span></p>
<p><span class="font8">Heinz, U., Adolph, H.,E. (2004). Metallo-β-lactamases: two binding sites for one catalic metal ion. &nbsp;&nbsp;&nbsp;&nbsp;Cell Mol Life</span></p>
<p><span class="font8">Sci</span><span class="font8" style="font-style:italic;">,</span><span class="font8"> 61, 2827-2839.</span></p>
<p><span class="font8">Hanson, N.,D., Hossain, A,, Buck, L., Moland, &nbsp;E.,S., Thomson, K.,S.</span></p>
<p><span class="font1">ISSN ONLINE: 9 772303 337 008</span></p>
<p><span class="font8">(2006) First occurrence of a </span><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa </span><span class="font8">isolate in the United States producing an IMP metallo-β-lactamase, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IMP-18.</span></p>
<p><span class="font8">Antimicrob Agents Chemother</span><span class="font8" style="font-style:italic;">.,</span><span class="font8"> 50, 2272-2273.</span></p>
<p><span class="font8">Lauretti, L., Riccio, M.,L., Mazzariol, A., </span><span class="font8" style="font-style:italic;">et al.</span><span class="font8"> &nbsp;&nbsp;&nbsp;&nbsp;(1999) &nbsp;&nbsp;&nbsp;&nbsp;Cloning &nbsp;&nbsp;&nbsp;&nbsp;and</span></p>
<p><span class="font8">characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a </span><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa</span><span class="font8"> clinical isolate. Antimicrob Agents Chemother, 43, 1584-1590.</span></p>
<p><span class="font8">Mahon, C.,R. &nbsp;&nbsp;(2011). Textbook of</span></p>
<p><span class="font8">Diagnostic Microbiology.</span></p>
<p><span class="font8">Poirel, L., Naas, T., Nicolas, D. (2000). Characterization &nbsp;&nbsp;of VIM-2, a</span></p>
<p><span class="font8">Carbapenem &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hydrolyzing</span></p>
<p><span class="font8">Metallo-β-Lactamase and its Plasmid and Integron-Borne Gene from a </span><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa </span><span class="font8">Clinical Isolate in France. Antimicrob Agents Chemother., 44, 891-897.</span></p>
<p><span class="font8">Shibata, N., Doi, Y., Yamane, K., </span><span class="font8" style="font-style:italic;">et al.</span><span class="font8">(2003). PCR Typing of Genetic determinats &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for &nbsp;&nbsp;&nbsp;&nbsp;metallo-β-l</span></p>
<p><span class="font8">actamases and integrases carried by gram-negative bacteria isolated in Japan with focus on the class 3 integron. J Clin Microbiol</span><span class="font8" style="font-style:italic;">.</span><span class="font8">, 41, 5407-5413.</span></p>
<p><span class="font8">Sepehriseresht, S., Boroumand, M.,A., Pourgholi, L., et al. (2012). Detection of VIM and IPM-type</span></p>
<p><span class="font8">Metallo-β-Lactamases &nbsp;&nbsp;&nbsp;&nbsp;in</span></p>
<p><span class="font8" style="font-style:italic;">Pseudomonas aeruginosa</span><span class="font8"> Clinical Isolates. Archives of Iranian</span></p>
<p><span class="font8">Medicine, 15(11), 670-673.</span></p>
<p><span class="font8">Sacha, P., Wieezorek, P., Hauschild, T., Zorawski, M., et al. (2008). Metallo-β-Lactamases of &nbsp;&nbsp;&nbsp;</span><span class="font8" style="font-style:italic;">Pseudomonas</span></p>
<p><span class="font8" style="font-style:italic;">aeruginosa</span><span class="font8"> – a Novel Mechanism Resistance to β-Lactam Antibiotics. Folia Histochemica &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Et</span></p>
<p><span class="font8">Cytobiologica, 46(2), 137-142.</span></p>
<p><span class="font8">Toleman, M.,A., Bennett, P.,M., Walsh, T.,R. (2006) ISCR Elements: novel gene-capturing systems of the 21st century?, Microbiol MolBiol Rev</span><span class="font8" style="font-style:italic;">., </span><span class="font8">70, 296-316.</span></p>
<p><span class="font8">Woodford, N., Turton, J., F., Livermore, D.,M. (2011). Multiresistant Gramnegative Bacteria: the Role of High-Risk Clones in the Dissemination of Antibiotic Resistance, FEMS Microbiol Rev, 35, 736-755.</span></p>
<p><span class="font8">Yan, J.,J., Hsueh, P.,R., Ko, W.,C., </span><span class="font8" style="font-style:italic;">et al. </span><span class="font8">(2001). Metallo-β-Lactamases &nbsp;in</span></p>
<p><span class="font8">clinical </span><span class="font8" style="font-style:italic;">Pseudomonas</span><span class="font8"> isolates &nbsp;&nbsp;&nbsp;&nbsp;in</span></p>
<p><span class="font8">Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. &nbsp;&nbsp;&nbsp;&nbsp;Antimicrob Agents</span></p>
<p><span class="font8">Chemother.</span><span class="font8" style="font-style:italic;">,</span><span class="font8"> 45, 2224-2228.</span></p>
<p><span class="font8">Zhao, W.,H., Chen, G., Ito, R., Qing Hu, Z. (2009). Relevance of Resistance Levels to &nbsp;&nbsp;&nbsp;&nbsp;Carbapenems &nbsp;&nbsp;&nbsp;and</span></p>
<p><span class="font8">Integron-Borne </span><span class="font8" style="font-style:italic;">bla</span><span class="font6">IMP-1</span><span class="font8">, </span><span class="font8" style="font-style:italic;">bla</span><span class="font6">IMP-7</span><span class="font8">, </span><span class="font8" style="font-style:italic;">bla</span><span class="font6">IMP-10</span><span class="font8">, and </span><span class="font8" style="font-style:italic;">bla</span><span class="font6">VIM-2 </span><span class="font8">in Clinical Isolates &nbsp;&nbsp;of &nbsp;</span><span class="font8" style="font-style:italic;">Pseudomonas</span></p>
<p><span class="font8" style="font-style:italic;">aeruginosa,</span><span class="font8"> Journal of Medical Microbiology, &nbsp;&nbsp;&nbsp;58, &nbsp;&nbsp;&nbsp;1080-1085.</span></p>
<p><span class="font5">36 </span><span class="font2">• </span><span class="font1">ASIA OCEANIA BIOSCIENCES AND BIOTECHNOLOGY CONSORTIUM</span></p>